The global most powerful information hub of high performance & advanced materials, innovative technologies

to market your brand and access to the global demand and supply markets

Johnson & Johnson acquires 3D printed spinal implant manufacturer Emerging Implant Technologies EIT

Restructuring of the orthopedic implant field has begun. At the beginning of September 2018, Stryker Corporation (NYSE: SYK), a Fortune 500 medical technology company, announced that it would pay $ 1.4 billion. Acquires 3D printed orthopedic implant company K2M

 

And just in the past half a month, on September 18, Johnson & Johnson Medical has acquired German 3D printed spinal implant manufacturer Emerging Implant Technologies (EIT).

 

EIT, based in Wurmlingen, Germany, is a privately held manufacturer of 3D printed titanium vertebral implants for spinal fusion surgery. The product utilizes EIT’s proprietary advanced technology, which consists of an open and interconnected porous structure designed to grow bone into the implant. These technologies will be available to patients around the world through Johnson & Johnson Medical Devices’ commercial infrastructure.

 

The acquisition enables Johnson & Johnson’s orthopedic business DePuy Synthes to enhance its comprehensive interbody implant portfolio, including expandable interbody devices, titanium PEEK technology and now 3D printed honeycomb titanium. EIT technology is designed to complement DePuy Synthes’ focus on minimally invasive and open spinal surgery for the intervertebral implantation segment.

 

“Our goal is to provide a complete portfolio of human solutions, giving surgeons more options for treating patients,” said Aldo Denti, chairman of DePuy Synthes Group. “We are excited to welcome EIT’s technical team as we work together to introduce technology that will enable surgeons to reliably perform spine fusion surgery and achieve consistent results.”

 

Johnson & Johnson says DePuy Synthes will continue to focus on solutions for disc disease, deformities and complex cervical diseases. DePuy Synthes will launch a variety of technologies, including intervertebral implants, support technologies, minimally invasive spine (MIS) and biomaterials.

Please check the message before sending